Transient receptor potential vanilloid subtype 1 mediates cell death of mesencephalic dopaminergic neurons in vivo and in vitro

被引:132
|
作者
Kim, SR
Lee, DY
Chung, ES
Oh, UT
Kim, SU
Jin, BK [1 ]
机构
[1] Ajou Univ, Sch Med, Brain Dis Res Ctr, Suwon 442749, South Korea
[2] Ajou Univ, Sch Med, Grad Program Neurosci, Suwon 442749, South Korea
[3] Seoul Natl Univ, Coll Pharm, Sensory Res Grp, Seoul 151742, South Korea
来源
JOURNAL OF NEUROSCIENCE | 2005年 / 25卷 / 03期
关键词
transient receptor potential vanilloid 1; capsaicin; capsazepine; anandamide; cannabinoid type-1 receptor; dopaminergic neurons;
D O I
10.1523/JNEUROSCI.4166-04.2005
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Intranigral injection of the transient receptor potential vanilloid subtype 1 (TRPV1; also known as VR1) agonist capsaicin ( CAP) into the rat brain, or treatment of rat mesencephalic cultures with CAP, resulted in cell death of dopaminergic (DA) neurons, as visualized by immunocytochemistry. This in vivo and in vitro effect was ameliorated by the TRPV1 antagonist capsazepine (CZP) or iodoresiniferatoxin, suggesting the direct involvement of TRPV1 in neurotoxicity. In cultures, both CAP and anandamide ( AEA), an endogenous ligand for both TRPV1 and cannabinoid type 1 (CB1) receptors, induced degeneration of DA neurons, increases in intracellular Ca2+ ([Ca2+](i)), and mitochondrial damage, which were inhibited by CZP, the CB1 antagonist N-(piperidin-1-yl)-5-(4-iodophenyl)-1( 2,4-dichlorophenyl)-4-methyl-1H-pyrazole-3-carboxamide (AM251) or the intracellular Ca2+ chelator BAPTA/AM. We also found that CAP or AEA increased mitochondrial cytochrome c release as well as immunoreactivity to cleaved caspase-3 and that the caspase-3 inhibitor z-Asp-Glu-Val-Asp-fmk protected DA neurons from CAP- or AEA-induced neurotoxicity. Additional studies demonstrated that treatment of mesencephalic cultures with CB1 receptor agonist (6aR)- trans 3-(1,1-dimethylheptyl)-6a,7,10,10a-tetrahydro-1-hydroxy-6,6- dimethyl-6H-dibenzo[b, d] pyran-9-methanol (HU210) also produced degeneration of DA neurons and increases in [Ca2+](i), which were inhibited by AM251 and BAPTA/AM. The CAP-, AEA-, or HU210-induced increases in [Ca2+](i) were dependent on extracellular Ca2+, with significantly different patterns of Ca2+ influx. Surprisingly, CZP and AM251 reversed HU210- or CAP- induced neurotoxicity by inhibiting Ca2+ influx, respectively, suggesting the existence of functional cross talk between TRPV1 and CB1 receptors. To our knowledge, this study is the first to demonstrate that the activation of TRPV1 and/or CB1 receptors mediates cell death of DA neurons. Our findings suggest that these two types of receptors, TRPV1 and CB1, may contribute to neurodegeneration in response to endogenous ligands such as AEA.
引用
收藏
页码:662 / 671
页数:10
相关论文
共 50 条
  • [1] Transient receptor potential vanilloid subtype 1 mediates microglial cell death in vivo and in vitro via Ca2+-mediated mitochondrial damage and cytochrome c release
    Kim, Sang R.
    Kim, Seung U.
    Oh, Uhtaek
    Jin, Byung K.
    JOURNAL OF IMMUNOLOGY, 2006, 177 (07): : 4322 - 4329
  • [2] Transient Receptor Potential Vanilloid 1 Expression Mediates Capsaicin-Induced Cell Death
    Ramirez-Barrantes, Ricardo
    Cordova, Claudio
    Gatica, Sebastian
    Rodriguez, Belen
    Lozano, Carlo
    Marchant, Ivanny
    Echeverria, Cesar
    Simon, Felipe
    Olivero, Pablo
    FRONTIERS IN PHYSIOLOGY, 2018, 9
  • [3] Transient receptor potential vanilloid subtype 1 contributes to mesencephalic dopaminergic neuronal survival by inhibiting microglia-originated oxidative stress
    Park, Eun S.
    Kim, Sang R.
    Jin, Byung K.
    BRAIN RESEARCH BULLETIN, 2012, 89 (3-4) : 92 - 96
  • [4] Dexmedetomidine modulates transient receptor potential vanilloid subtype 1
    Lee, Byeong-Min
    Jang, Yoonsun
    Park, Giyeon
    Kim, Kwanwoo
    Oh, Sang Ho
    Shin, Teo Jeon
    Chung, Gehoon
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2020, 522 (04) : 832 - 837
  • [5] Propofol Restores Transient Receptor Potential Vanilloid Receptor Subtype-1 Sensitivity via Activation of Transient Receptor Potential Ankyrin Receptor Subtype-1 in Sensory Neurons
    Zhang, Hongyu
    Wickley, Peter J.
    Sinha, Sayantani
    Bratz, Ian N.
    Damron, Derek S.
    ANESTHESIOLOGY, 2011, 114 (05) : 1169 - 1179
  • [6] Transient receptor potential vanilloid 1 mediates pain in mice with severe sickle cell disease
    Hillery, Cheryl A.
    Kerstein, Patrick C.
    Vilceanu, Daniel
    Barabas, Marie E.
    Retherford, Dawn
    Brandow, Amanda M.
    Wandersee, Nancy J.
    Stucky, Cheryl L.
    BLOOD, 2011, 118 (12) : 3376 - 3383
  • [7] Transient receptor potential vanilloid subtype 1: A potential therapeutic target for fibrotic diseases
    Peng, Guangxin
    Tang, Xiaoling
    Gui, Yang
    Yang, Jing
    Ye, Lifang
    Wu, Liuyang
    Ding, Ya Hui
    Wang, Lihong
    FRONTIERS IN PHYSIOLOGY, 2022, 13
  • [8] Involvement of Transient Receptor Potential Vanilloid Subtype 1 in Analgesic Action of Methylsalicylate
    Ohta, Toshio
    Imagawa, Toshiaki
    Ito, Shigeo
    MOLECULAR PHARMACOLOGY, 2009, 75 (02) : 307 - 317
  • [9] Activation of the Human Transient Receptor Potential Vanilloid Subtype 1 by Essential Oils
    Ohkawara, Susumu
    Tanaka-Kagawa, Toshiko
    Furukawa, Yoko
    Nishimura, Tetsuji
    Jinno, Hideto
    BIOLOGICAL & PHARMACEUTICAL BULLETIN, 2010, 33 (08) : 1434 - 1437
  • [10] TRANSIENT RECEPTOR POTENTIAL VANILLOID 2 MEDIATES MYOCYTE CONTRACTILITY
    Rubinstein, J.
    Koch, S. E.
    Lasko, V.
    Patel, A.
    Jiang, M.
    Singh, V.
    Jones, W.
    Lorenz, J.
    JOURNAL OF INVESTIGATIVE MEDICINE, 2013, 61 (04) : 767 - 767